Literature DB >> 24965269

[Implementation of ethics services. Opportunities and obstacles].

F Salomon1.   

Abstract

BACKGROUND: Medical success in the last century has caused situations, in which the question arises whether therapy is right. In the same time autonomy has become more and more important. Furthermore, human beings want to decide on health, life and dying. APPROACH: Experience of limitations of life and desire of autonomy in healthcare lead to ethical questions. Different ethical services were established to deal with and to solve problems. Ethics committees with multiprofessional members and different qualifications will give guidance in critical decision making. Ethics services do not receive responsibility for the decision, but helps those who are responsible by structured reflection, estimation of values and including all concerned. DISCUSSION: Implementing ethics services also encounters obstructions and scepticism. Time, responsibility for therapy and criticism of customs and structures must be considered to perpetuate success. Instructions for implementing ethics services are presented.

Entities:  

Mesh:

Year:  2014        PMID: 24965269     DOI: 10.1007/s00063-014-0393-9

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  3 in total

1.  Development of clinical ethics services in the UK: a national survey.

Authors:  Anne Marie Slowther; Leah McClimans; Charlotte Price
Journal:  J Med Ethics       Date:  2011-12-13       Impact factor: 2.903

2.  Physicians' Ethics Forum: a Web-based ethics consultation service.

Authors:  Pekka Louhiala; Samuli Saarni; Katri Hietala; Amos Pasternack
Journal:  J Med Ethics       Date:  2011-06-29       Impact factor: 2.903

3.  Implementing structured, multiprofessional medical ethical decision-making in a neonatal intensive care unit.

Authors:  Jacoba Coby de Boer; Geja van Blijderveen; Gert van Dijk; Hugo J Duivenvoorden; Monique Williams
Journal:  J Med Ethics       Date:  2012-05-25       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.